Clinical Trial Update: Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating PRO-155 for inflammation of the conjunctival surface in Grade I-III pterygium versus placebo; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Ocular Pain
• Pterygium

Drugs mentioned

• PRO-155

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Pterygium, Ocular Pain | Phase 4 | Status: COMPLETED | Results posted: 2019-11-20